title: Number of ganglion cells in glaucoma eyes compared with threshold visual field tests in the same persons.
abstract: OBJECTIVE
  To compare the number of retinal ganglion cells (RGCs) topographically mapped with specific visual field threshold test data in the same eyes among glaucoma patients.
  
  
  METHODS
  Seventeen eyes of 13 persons with well-documented glaucoma histories and Humphrey threshold visual field tests (San Leandro, CA) were obtained from eye banks. RGC number was estimated by histologic counts of retinal sections and by counts of remaining axons in the optic nerves. The locations of the retinal samples corresponded to specific test points in the visual field. The data for glaucoma patients were compared with 17 eyes of 17 persons who were group matched for age, had no ocular history, and had normal eyes by histologic examination.
  
  
  RESULTS
  The mean RGC loss for the entire retina averaged 10.2%, indicating that many eyes had early glaucoma damage. RGC body loss averaged 35.7% in eyes with corrected pattern SD probability less than 0.5%. When upper to lower retina RGC counts were compared with their corresponding visual field data within each eye, a 5-dB loss in sensitivity was associated with 25% RGC loss. For individual points that were abnormal at a probability less than 0.5%, the mean RGC loss was 29%. In control eyes, the loss of RGCs with age was estimated as 7205 cells per year in persons between 55 and 95 years of age. In optic nerves from glaucoma subjects, smaller axons were significantly more likely to be present than larger axons (R2 = 0.78, P<0.001).
  
  
  CONCLUSIONS
  At least 25% to 35% RGC loss is associated with statistical abnormalities in automated visual field testing. In addition, these data corroborate previous findings that RGCs with larger diameter axons preferentially die in glaucoma.
authors.affiliation: Glaucoma Service and Dana Center for Preventive Ophthalmology, Wilmer Institute, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.
authors.forename: L A
authors.initials: LA
authors.lastname: Kerrigan-Baumrind
authors.forename: H A
authors.initials: HA
authors.lastname: Quigley
authors.forename: M E
authors.initials: ME
authors.lastname: Pease
authors.forename: D F
authors.initials: DF
authors.lastname: Kerrigan
authors.forename: R S
authors.initials: RS
authors.lastname: Mitchell
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D001369:Axons / Q000473:pathology; D002452:Cell Count; D016923:Cell Death; D005260:Female; D005901:Glaucoma / Q000473:pathology*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009900:Optic Nerve / Q000473:pathology; D012165:Retinal Ganglion Cells / Q000473:pathology*; D012684:Sensory Thresholds; D058609:Visual Field Tests; D014794:Visual Fields